Driven by an unwavering commitment to its cause, IDEXX is a constituent of the S&P 500 and a major contributor to pet healthcare innovation. The company provides a diverse range of diagnostic and information technology-based products and services to practicing veterinarians globally. Its offerings include in-clinic diagnostic tests, instrumentation, reference laboratory and telemedicine consultation services, and practice management software, all geared towards enabling veterinarians to administer advanced medical care, enhance staff efficiency, and develop economically successful practices.
In addition to its focus on pet health, IDEXX also dedicates itself to the global production animal industry, producing diagnostic tests and information for poultry and livestock. Moreover, the company is involved in developing tests to ensure the quality and safety of water and milk.
Although the company's most recent investment, a Seed Round investment, dates back to 01 January 1984, it garnered support from Venrock, signifying the confidence and backing of prominent investors in IDEXX's endeavors. As the global market for pet health continues to expand, IDEXX stands poised to further its impact in enhancing the well-being of pets, people, and livestock worldwide.